SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing a surge in investor interest driven by strong technical momentum and persistent talk of a potential short squeeze, as shares approach a key resistance level near $30. The community is actively discussing the stock's growth potential fueled by upcoming peptide announcements and the recent expansion of GLP-1 weight-loss offerings.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing an intense momentum-driven rally, fueled by surging enterprise AI storage demand and persistent short-covering as the stock breaks psychological price barriers. While the community remains deeply divided, with some investors betting on continued multi-bagger growth and others warning of a speculative bubble, the core debate centers on whether the current momentum can survive the ongoing geopolitical uncertainty surrounding regional peace negotiations.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are surging following a strong quarterly earnings report that featured a significant beat on revenue and a subscriber milestone of over 100 million households. The community is actively discussing the wave of positive analyst price target hikes and questioning whether the stock can maintain this momentum toward higher levels.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors due to positive Phase 3 data for its gene-editing therapy, with the community closely tracking the stock's potential for a short squeeze alongside institutional accumulation and upcoming regulatory milestones. Traders are actively debating the impact of a recent share offering and the company's long-term commercialization prospects, viewing the current price as an inflection point for the stock's valuation.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors grapple with conflicting sentiment, ranging from long-term value-based optimism regarding its AI and cloud infrastructure to intense frustration over persistent price stagnation and geopolitical regulatory pressures. The community remains deeply polarized, with many retail traders debating whether the stock serves as a prime opportunity for accumulation at historical discounts or remains a structurally compromised value trap.

Elastic NV is a data analytics company, which engages in the provision of open-source search and analytics engine services. It operates through the United States, the Netherlands, United Kingdom, India, and Rest of World geographical segments. The company was founded by Shay Banon, Uri Boness, Steven Schuurman, and Simon Willnauer on February 9, 2012 and is headquartered in San Francisco, CA.

Elastic N.V

Elastic is seeing heightened interest from investors who are actively trading options and monitoring technical breakout levels, fueled by a narrative that the company's search and data-analytics platform is essential for enterprise AI adoption. While some community members remain skeptical of the stock's volatility and historical price performance, others are treating recent dips as accumulation opportunities, focusing on its potential as a recurring revenue leader in the software space.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is seeing heavy volatility and selling pressure following the abrupt resignation of its CEO, Mike Lyons, who departed to lead Truist Financial. While the company reaffirmed its financial outlook and appointed Takis Georgakopoulos as his successor, investors remain divided, with some viewing the leadership change as a necessary pivot and others expressing concerns over the stability of the turnaround strategy.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is experiencing significant institutional momentum, highlighted by a sharp increase in price targets from analysts at firms like Morgan Stanley and Bernstein, who cite the company's successful pivot from Bitcoin mining to high-performance AI infrastructure as a major catalyst. The community is actively discussing the stock's potential for further upside as they monitor progress on the company's multi-gigawatt development pipeline and the highly anticipated announcement of a new customer for its Kentucky site.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense community debate as investors weigh the stock's recent volatility against its potential as an AI infrastructure play, with many bullish participants pointing to recent hiring activity and capacity expansion as indicators of underlying demand. While short-term traders track technical support levels and broader market macro pressures, long-term holders remain focused on upcoming catalyst events and potential institutional re-positioning.

BTQ Technologies Corp. engages in the business of post-quantum encryption. Its products include: QCIM, QSSN, OSS, QPoW, QRiNG. The company was founded by Nicolas Roussy Newton on Novemeber 23, 1983 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is drawing significant community attention as investors debate its role in the quantum-secure infrastructure sector, with discussion centered on technical support levels and speculation regarding potential commercial contracts or acquisition activity. While some traders are focused on technical chart patterns and potential bottoming, others remain cautious due to limited commercial revenue and ongoing public disputes within the company's leadership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

REGN Expands Cancer Deal With CytomX for Bispecific Therapeutics 

Regeneron expands its CytomX partnership to develop conditionally activated bispecific cancer therapies, with potential milestones nearing $4 billion.

CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of +29.58% and +193.76%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates

Mirum Pharmaceuticals (MIRM) delivered earnings and revenue surprises of +3.47% and +8.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday

CytomX Therapeutics (NASDAQ:CTMX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-cytomx-therapeutics-inc-stock...

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Analysts

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and nine have assigned...

Wall Street Zen Downgrades CytomX Therapeutics (NASDAQ:CTMX) to Strong Sell

Wall Street Zen lowered shares of CytomX Therapeutics from a "sell" rating to a "strong sell" rating in a research note on Saturday...

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Crosses Below 50-Day Moving Average - Here's What Happened

CytomX Therapeutics (NASDAQ:CTMX) Share Price Passes Below 50-Day Moving Average - What's Next...

Traders Buy High Volume of CytomX Therapeutics Put Options (NASDAQ:CTMX)

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) was the recipient of some unusual options trading activity on Thursday. Stock traders acquired 13,090 put options on the company. This...

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 6.3%  - Time to Buy?

CytomX Therapeutics (NASDAQ:CTMX) Trading Up 6.3% - What's Next...

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Moderate Buy" by Brokerages

Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten brokerages that are covering the stock, MarketBeat Ratings...

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Current Price	$3.04
Prev Close	$3.01
Open	$3.05
Dividend Yield	0.00%
50-Day Moving Average	$3.93
Beta	1.48
Avg. Volume	3.08M
PE Ratio	-8.27

52-Week High	$8.21
52-Week Low	$1.72
Market Capitalization	$655.29M
EPS (Annual)	-$0.1477
Price to Book	2.05
Revenue Per Employee	$1.1M

CTMXCytomX Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTMX News